300+ investors in your industry, stage, and region Get
Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Venture Capital
Recruiting
Web3
Social
Medical
Theatre
Infrastructure
Climate
LGBT
Beauty
Fashion
Cannabis
Life Science
Celebrity
Food and Beverage
Music
Publishing
Art
Mobile Apps
Real Estate
Wine and Spirits
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Franchise
Financial Services
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Morocco
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Access Full Database - Free Forever
Open database
CG Health Ventures, VC Fund

CG Health Ventures

VC Fund

Barcelona, Spain

CG Health Ventures is a venture capital firm that seeks to invest in the health IT, digital health and genomics domain.

Total investments:
10
Last investment:
Lead investor:
20%

Last updated:

Industries CG Health Ventures invests in

Health CareBiotechnologyGeneticsWellnessSports

Stages CG Health Ventures invests in

SeedSeries AConvertible Note

Countries CG Health Ventures invests in

United StatesSpain

Round sizes

Seed $549k–$6MSeries A $7.7M–$37M

Contacts

NameEmailPhoneSocials

Sign up to unlock verified contacts

Unlock Contacts

Round size

Seed
$549k–$6M
Series A
$7.7M–$37M

Investment Focus

Industry

  • Health Care 9 (90%)
  • Biotechnology 4 (40%)
  • Genetics 2 (20%)
  • Wellness 2 (20%)
  • Sports 1 (10%)
See all 18 industries →

Stage

  • Seed 6 (60%)
  • Series A 3 (30%)
  • Convertible Note 1 (10%)

Country

  • United States 5 (50%)
  • Spain 4 (40%)

Team

NameTitleInvestmentsLinksEmail
Carlos Gallardo
Carlos Gallardo Founder & Managing Director
Founder & Managing Director Total investments: 2
Find email

Investments

CompanyDescriptionRoundLinks
Cercle advances women's healthcare by unlocking access to insights. Cercle’s platform, the Cercle Biomedical Graph™, transforms healthcare data at scale into real-time, high-quality insights that women's healthcare providers use to run more efficient businesses and provide personalized care. $6M / Seed / Sep 18, 2024
Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies. $7.7M / Series A / Jun 28, 2022
Psious develops a virtual reality platform designed to bring value to mental health treatment. The company's platform uses hyper-realistic virtual environments to treat anxiety disorders by means of virtual exposure therapy, enabling professionals to improve mental health therapies. $7.4M / Convertible Note / Jun 28, 2022
Skingdom is a new digital e-health startup, Coachmetics aims to become the international reference in wellness coaching. Seed / Sep 18, 2017
Babyscripts’ three-tiered approach to virtual maternity care allows providers to deliver risk-specific care to pregnant mothers at any time, in any place. The first tier consists of a digital education layer delivered via a mobile app, with daily gestational-age and practice-specific, customizable content extending through one year postpartum toengage and empower pregnant mothers through trusted resources. The second tier enables virtual management of pregnant patients through the addition of remote monitoring. Depending on the risk, patients are provided with medical devices (like a bluetooth-enabled blood pressure cuff) to monitor for elevated risk, alerting the provider through a unique trigger alert system to enable risk management and intervention. This smart end-to-end management of patients enables the provider to transition care outside of the clinic and address problems of access, allowing them to automate a majority of their patient care while more effectively allocating time and resources to higher-risk patients. The third tier brings the insurer into the equation in a unique collaboration between the care team and payer, solving some of the structural issues of care coordination and access to care, improving outcomes while reducing cost. $7.7M / Series A / Jul 20, 2017
Virta develops treatments to reversing type 2 diabetes without medications or surgery. Among enrolled patients in its clinical trial at one year, 60% achieved diabetes reversal, and 94% of insulin users reduced or eliminated usage altogether. Results extend beyond diabetes reversal to other areas of metabolic and cardiovascular health, withsustained improvements in blood pressure, inflammation, liver function, and BMI. Delivered through Virta’s novel continuous remote care platform, the Virta Treatment provides unparalleled medical and behavioral support and is transforming the lives of people living with type 2 diabetes. Founded in 2014, the company is headquartered in San Francisco, California. $37M / Series A / Mar 08, 2017
S-Biomedic brings novel therapeutic solutions to the skin microbiome.The skin microbiome - a habitat of billions of beneficial and harmful bacteria - contributes to healthy skin. An imbalance of these bacteria can lead to a variety of skin conditions including acne, eczema, rosacea and ageing. S-Biomedic uses a targeted modulation-based technologyto modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industries. They design their products using the latest advances in microbiology and dermatology. Using their technology, beneficial bacteria are selected and combined to generate products that accelerate the rebalancing of a disease microbiome. In this way, they are able to restore a healthy state back to your skin. Seed / Oct 06, 2016
Genomcore is a professional bioinformatics framework with focus on privacy, compliance and collaborative analysis designed for a broad implementation of precision medicine in a clinical context. Made of Genes is a personal genomics service spined-off from Genomcore. $549K / Seed / Sep 09, 2016
At MADE OF GENES, we utilize artificial intelligence to integrate molecular and health data, providing personalized, rigorous, and 100% actionable guidelines in various health areas such as nutrition, emotional well-being, sports, and healthy aging, turning big data into smart data. $561.6K / Seed / Sep 09, 2016
Medtep is personalized medicine. They focus on disease prevention through monitoring of people's life habits. With uClinics and uPatient They aggregate and merge any kind of data (from apps, devices, sensors, etc.), so the needed information can be given in a comprehensible way to any patient through a healthcare professional. They upgrademonitoring processes to make an impact on the patient and help condition their behavior. As a response, patients learn more about their treatments and understand they are jointly responsible of their own health and welfare. They work with Pharmaceutical companies, Clinical laboratories, Medical societies, Insurance companies, Sports clubs, Patient associations, Foundations and Universities and R&D around the world. $2M / Seed / Jul 14, 2015

Co-Investors

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Find investors for your startup

Search 48,091 investors by industry and country. Emails and phones included.

Any industry
Video Games
Hospitality
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Artificial Intelligence
Social Impact
SaaS
Energy
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Retail
Oil and Gas
Film
Payments
Marketplace
Fitness
Organic Food
Machine Learning
Agriculture (AgTech)
Gaming
Facebook
Blockchain
B2B
Social Network
Medical Device
Education
Wellness
Sports
Automotive
eSports
Legal
Biotechnology
Renewable Energy
Software
Crowdfunding
Venture Capital
Recruiting
Web3
Social
Medical
Theatre
Infrastructure
Climate
LGBT
Beauty
Fashion
Cannabis
Life Science
Celebrity
Food and Beverage
Music
Publishing
Art
Mobile Apps
Real Estate
Wine and Spirits
Sporting Goods
Manufacturing
FinTech
Finance
Digital Media
Social Media
Franchise
Financial Services
Non Profit
Internet
Mobile Advertising
Android
Proptech
Impact
Sustainability
Hardware
Biotech
Enterprise
Transportation
Community
Media (Entertainment)
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
South Korea
Japan
Burkina Faso
Africa
Singapore
Gibraltar
Egypt
Taiwan
Zimbabwe
Tunisia
Sweden
Oceania
Hong Kong
Nigeria
Togo
Croatia
Iran
Guinea
Haiti
Kyrgyzstan
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Romania
Brazil
LATAM
Poland
Oman
Puerto Rico
Cameroon
Guernsey
Colombia
China
Armenia
Costa Rica
Czech Republic
Kuwait
Kenya
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
New Zealand
Australia
Saudi Arabia
Sri Lanka
Jamaica
Guatemala
Switzerland
Kazakhstan
Cayman Islands
Morocco
Venezuela
Myanmar
Uganda
Turkey
Uruguay
Botswana
Moldova
Seychelles
Paraguay
South Africa
Canada
Ireland
France
Denmark
Georgia
Ghana
Iraq
Latvia
Mali
Malaysia
Philippines
Portugal
Rwanda
Sierra Leone
El Salvador
Senegal
Tanzania
India
Germany
United States
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Europe
Qatar
Angola
Cyprus
Argentina
Bangladesh
Barbados
Belgium
Jordan
Ethiopia
Austria
Azerbaijan
Bulgaria
Ecuador
Faroe Islands
Jersey
Bahrain
Estonia
Bahamas
Bolivia
Belize
Algeria
Italy
Belarus
Finland
Hungary
Grenada
Israel
Lithuania
Honduras
Iceland
Cambodia
Liechtenstein
Lebanon
Mongolia
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors

Similar Investors

Recommended lists

FAQ

What does CG Health Ventures invest in?

CG Health Ventures invests primarily in Health Care, Biotechnology and Genetics startups, most often at Seed and Series A stage. Most of the 10 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

What round sizes does CG Health Ventures invest in?

CG Health Ventures typically joins rounds of $549k–$6M at Seed and $7.7M–$37M at Series A. These are whole funding-round sizes, not CG Health Ventures's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds CG Health Ventures took part in.

How do I contact CG Health Ventures?

Public channels for CG Health Ventures include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

Who are the partners at CG Health Ventures?

The team at CG Health Ventures includes Carlos Gallardo (Founder & Managing Director). The Team section lists each member with their title, investment count and links.

Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

Contact your first 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!
CG Health Ventures CG Health Ventures Find emails